Rockland Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $282K | Sell |
778
-135
| -15% | -$46.2K | 0.01% | 280 |
|
|
2026
Q1 | $321K | Sell |
913
-707
| -44% | -$252K | 0.01% | 269 |
|
|
2025
Q4 | $530K | Buy |
1,620
+144
| +10% | +$45.7K | 0.02% | 216 |
|
|
2025
Q3 | $417K | Sell |
1,476
-50
| -3% | -$14.5K | 0.02% | 230 |
|
|
2025
Q2 | $426K | Sell |
1,526
-916
| -38% | -$259K | 0.02% | 188 |
|
|
2025
Q1 | $761K | Sell |
2,442
-357
| -13% | -$105K | 0.04% | 151 |
|
|
2024
Q4 | $730K | Sell |
2,799
-129
| -4% | -$38.3K | 0.04% | 162 |
|
|
2024
Q3 | $943K | Sell |
2,928
-138
| -5% | -$45.1K | 0.05% | 145 |
|
|
2024
Q2 | $958K | Buy |
3,066
+21
| +0.7% | +$6.17K | 0.05% | 138 |
|
|
2024
Q1 | $866K | Buy |
3,045
+64
| +2% | +$18.7K | 0.05% | 154 |
|
|
2023
Q4 | $859K | Sell |
2,981
-34
| -1% | -$9.26K | 0.05% | 157 |
|
|
2023
Q3 | $810K | Sell |
3,015
-89
| -3% | -$22.2K | 0.05% | 149 |
|
|
2023
Q2 | $689K | Buy |
3,104
+20
| +0.6% | +$4.64K | 0.04% | 171 |
|
|
2023
Q1 | $746K | Sell |
3,084
-543
| -15% | -$133K | 0.05% | 160 |
|
|
2022
Q4 | $952K | Sell |
3,627
-232
| -6% | -$62.2K | 0.06% | 149 |
|
|
2022
Q3 | $870K | Sell |
3,859
-293
| -7% | -$71K | 0.06% | 137 |
|
|
2022
Q2 | $1.01M | Sell |
4,152
-267
| -6% | -$65.4K | 0.07% | 130 |
|
|
2022
Q1 | $1.07M | Sell |
4,419
-351
| -7% | -$80.6K | 0.07% | 132 |
|
|
2021
Q4 | $1.07M | Buy |
4,770
+395
| +9% | +$83.4K | 0.07% | 142 |
|
|
2021
Q3 | $930K | Buy |
4,375
+519
| +13% | +$119K | 0.06% | 144 |
|
|
2021
Q2 | $940K | Sell |
3,856
-1,069
| -22% | -$263K | 0.07% | 146 |
|
|
2021
Q1 | $1.23M | Sell |
4,925
-330
| -6% | -$78.7K | 0.09% | 125 |
|
|
2020
Q4 | $1.21M | Buy |
5,255
+272
| +5% | +$62.7K | 0.09% | 121 |
|
|
2020
Q3 | $1.27M | Buy |
4,983
+339
| +7% | +$84K | 0.11% | 112 |
|
|
2020
Q2 | $1.1M | Sell |
4,644
-257
| -5% | -$58.6K | 0.1% | 117 |
|
|
2020
Q1 | $995K | Sell |
4,901
-2,804
| -36% | -$612K | 0.1% | 115 |
|
|
2019
Q4 | $1.86M | Buy |
7,705
+449
| +6% | +$99K | 0.15% | 94 |
|
|
2019
Q3 | $1.4M | Buy |
7,256
+2,753
| +61% | +$528K | 0.13% | 109 |
|
|
2019
Q2 | $830K | Buy |
4,503
+175
| +4% | +$31.3K | 0.08% | 142 |
|
|
2019
Q1 | $823K | Buy |
4,328
+156
| +4% | +$29.8K | 0.09% | 140 |
|
|
2018
Q4 | $812K | Sell |
4,172
-13
| -0.3% | -$2.54K | 0.1% | 135 |
|
|
2018
Q3 | $868K | Buy |
4,185
+271
| +7% | +$53.4K | 0.11% | 117 |
|
|
2018
Q2 | $722K | Sell |
3,914
-515
| -12% | -$91.1K | 0.09% | 124 |
|
|
2018
Q1 | $755K | Buy |
4,429
+1,643
| +59% | +$302K | 0.1% | 122 |
|
|
2017
Q4 | $484K | Buy |
2,786
+1,576
| +130% | +$279K | 0.06% | 140 |
|
|
2017
Q3 | $226K | Sell |
1,210
-40
| -3% | -$7.09K | 0.03% | 153 |
|
|
2017
Q2 | $215K | Sell |
1,250
-84
| -6% | -$13.7K | 0.03% | 157 |
|
|
2017
Q1 | $219K | Buy |
+1,334
| New | +$222K | 0.03% | 152 |
|
Other funds holding AMGN
FFM
SP
Rockland Trust's AMGN Position: Q2 2026 in Review
Rockland Trust reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $46.2K and leaving 778 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #280.
Rockland Trust first reported a position in AMGN in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.86M in Q4 2019. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Rockland Trust held 778 shares of Amgen worth $282K as of Q2 2026.
- Rockland Trust sold 135 Amgen shares in Q2 2026, an estimated $46.2K.
- Amgen made up 0.01% of Rockland Trust's portfolio in Q2 2026, its #280 holding.
- Rockland Trust first reported a position in Amgen in Q1 2017 and has held it in 38 quarters since.
- Rockland Trust's Amgen position peaked at $1.86M in Q4 2019.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.